Dec 20 (Reuters) - UK's competition regulator will refer Australian hearing device maker Cochlear's (COH) acquisition of Copenhagen-based Demant's DEMANT.CO hearing implants business Oticon Medical for an in-depth investigation.
UK's Competition and Markets Authority (CMA) said on Tuesday it will refer the 850 million Danish crowns ($121.14 million) deal to a phase 2 investigation as it could threaten competition. ($1 = 7.0167 Danish crowns)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
4.170(1.33%) |
Mkt cap ! $20.73B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.91 | $313.71 | $43.40M | 137.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 324 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.18 | 55 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |